Literature DB >> 26617832

Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.

Ming Zhao1, Xiaodong Teng2, Guoqing Ru1, Zhongsheng Zhao1, Qinqin Hu1, Likai Han1, Xianglei He1.   

Abstract

Tubulocystic renal cell carcinoma (TCRCC) is a rare, recently characterized RCC subtype with distinctive clinicopathologic and genetic characterizations as well as typical behaviors in an indolent fashion. However, sporadic case reports in the literature have indicated that TCRCC with sarcomatoid differentiation or poorly differentiated (PD) foci could behave aggressively. Herein, we reported two cases of TCRCC with PD foci indentified from our consultative service. Both patients were male and aged 66 y and 47 y, respectively. The first patient experienced radical nephrectomy while the other was treated by partial nephrectomy. Macroscopically, both tumors were described as partly cystic and solid with the greatest diameter measuring of 12-cm and 4.5-cm, respectively. Histologically, both lesions had classic areas of TCRCC occupying most part of the tumor with small papillary RCC component. In case one, PD foci were scatteredly distributed and mixed with TCRCC and papillary RCC components, while in the other case the PD foci were adjacent to the areas of TCRCC. In both tumors, the PD foci were composed of irregular, often angulated, small tubules lined by atypical eosinophilic cells and surrounded by desmoplastic stroma, resembling collecting duct carcinoma. Immunohistochemistry, in both tumors, both TCRCC component and PD foci showed the similar immunoprofiles, i.e., labeling strongly and diffusely with PAX8, AMACR and Vimentin, and focally with CK34βE12 but not with renal cell carcinoma marker or P63. In case one, the tumor invaded extensively into the adjacent renal parenchyma and focally into both renal sinusal and perirenal adipose tissues. The patient had metastasis in the pelvic cavity at the time of diagnosis and succumbed to the disease without further treatment 3 months later. The other case was organ confined but with focal positive renal parenchymal margin. The patient subsequently underwent radical nephrectomy and was in a good status without evidence of tumor recurrence or metastasis at a follow-up of 8 months.

Entities:  

Keywords:  RCC; Tubulocystic renal cell carcinoma; collecting duct carcinoma; poorly differentiated foci; tubulocystic carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26617832      PMCID: PMC4637647     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Authors:  Satish K Tickoo; Mariza N dePeralta-Venturina; Lara R Harik; Heath D Worcester; Mohamed E Salama; Andrew N Young; Holger Moch; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

2.  Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report.

Authors:  M Mego; Z Sycova-Mila; K Rejlekova; B Rychly; J Obertova; J Rajec; O Hes; J Mardiak
Journal:  Ann Oncol       Date:  2008-07-08       Impact factor: 32.976

3.  Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin.

Authors:  G T MacLennan; G M Farrow; D G Bostwick
Journal:  Urology       Date:  1997-11       Impact factor: 2.649

4.  Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm.

Authors:  Mahul B Amin; Ruta Gupta; Hes Ondrej; Jesse K McKenney; Michal Michal; Andrew N Young; Gladell P Paner; Kerstin Junker; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

Review 5.  Uncommon and recently described renal carcinomas.

Authors:  John R Srigley; Brett Delahunt
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

6.  The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome.

Authors:  Maria J Merino; Carlos Torres-Cabala; Peter Pinto; William Marston Linehan
Journal:  Am J Surg Pathol       Date:  2007-10       Impact factor: 6.394

7.  Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.

Authors:  Ming Zhou; Ximing J Yang; Jose I Lopez; Rajal B Shah; Ondrej Hes; Steven S Shen; Rongshan Li; Yu Yang; Fan Lin; Paul Elson; Linda Sercia; Cristina Magi-Galluzzi; Ray Tubbs
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

8.  Tubulocystic carcinoma of the kidney: a new entity among renal tumors.

Authors:  Sandy Azoulay; Annick Vieillefond; François Paraf; Dominique Pasquier; Olivier Cussenot; Patrice Callard; Mathilde Sibony
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

9.  Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.

Authors:  Mahul B Amin; Gregory T MacLennan; Ruta Gupta; David Grignon; Francois Paraf; Annick Vieillefond; Gladell P Paner; Mark Stovsky; Andrew N Young; John R Srigley; John C Cheville
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

10.  Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.

Authors:  Ximing J Yang; Ming Zhou; Ondrej Hes; Steven Shen; Rongshan Li; Jose Lopez; Rajal B Shah; Yu Yang; Shang-Tian Chuang; Fan Lin; Maria M Tretiakova; Eric J Kort; Bin Tean Teh
Journal:  Am J Surg Pathol       Date:  2008-02       Impact factor: 6.394

View more
  3 in total

1.  Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.

Authors:  Steven C Smith; Kiril Trpkov; Ying-Bei Chen; Rohit Mehra; Deepika Sirohi; Chisato Ohe; Andi K Cani; Daniel H Hovelson; Kei Omata; Jonathan B McHugh; Wolfram Jochum; Maurizio Colecchia; Mitual Amin; Mukul K Divatia; Ondřej Hes; Santosh Menon; Isabela Werneck da Cunha; Sergio Tripodi; Fadi Brimo; Anthony J Gill; Adeboye O Osunkoya; Cristina Magi-Galluzzi; Mathilde Sibony; Sean R Williamson; Gabriella Nesi; Maria M Picken; Fiona Maclean; Abbas Agaimy; Liang Cheng; Jonathan I Epstein; Victor E Reuter; Satish K Tickoo; Scott A Tomlins; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2016-11       Impact factor: 6.394

Review 2.  Management of Atypical Renal Cell Carcinomas.

Authors:  Bobby C Liaw; Reza Mehrazin; Charles Baker; John P Sfakianos; Che-Kai Tsao
Journal:  Curr Treat Options Oncol       Date:  2017-09-14

3.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Ondrej Hes; Sean R Williamson; Anthony J Gill; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-03-04       Impact factor: 8.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.